These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

51 related articles for article (PubMed ID: 733631)

  • 1. [Pharmacokinetics of mefenamic acid in patients with liver cirrhosis].
    Tkaczewski W; Adamska-Dyniewska H; Gajewska B; Kowalczyk L
    Pol Tyg Lek; 1978 Dec; 33(52):1997-9. PubMed ID: 733631
    [No Abstract]   [Full Text] [Related]  

  • 2. [Mefenamic acid pharmacokinetics in patients with congestive heart failure].
    Adamska-Dyniewska H; Kowalczyk L; Tkaczewski W
    Pol Tyg Lek; 1979 Jan; 34(5):177-80. PubMed ID: 432132
    [No Abstract]   [Full Text] [Related]  

  • 3. [Ibuprofen pharmacokinetics in patients with liver cirrhosis].
    Adamska-Dyniewska H; Tkaczewski W; Gajewska B
    Wiad Lek; 1982 Jun; 35(10):609-13. PubMed ID: 7135956
    [No Abstract]   [Full Text] [Related]  

  • 4. Oral and intravenous pharmacokinetics of ranitidine in patients with liver cirrhosis.
    Okolicsanyi L; Venuti M; Strazzabosco M; Orlando R; Nassuato G; Iemmolo RM; Lirussi F; Muraca M; Pastorino AM; Castelli G
    Int J Clin Pharmacol Ther Toxicol; 1984 Jun; 22(6):329-32. PubMed ID: 6086536
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics of Josamycin in patients with liver cirrhosis and Gilbert's syndrome after repeated doses.
    Okolicsanyi L; Venuti M; Strazzabosco M; Biral A; Orlando R; Iemmolo RM; Nassuato G; Muraca M; Padrini G; Miglioli PA
    Int J Clin Pharmacol Ther Toxicol; 1985 Aug; 23(8):434-8. PubMed ID: 4044077
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Changes in metildigoxin pharmacokinetics in cirrhosis of the liver: a comparison with beta-acetyldigoxin.
    Rameis H; Woodcock B; Bonelli J; Waginger H
    Int J Clin Pharmacol Ther Toxicol; 1984 Mar; 22(3):145-51. PubMed ID: 6715083
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Verapamil pharmacokinetics and liver function in patients with cirrhosis.
    Finucci GF; Padrini R; Piovan D; Melica E; Merkel C; Gatta A; Zuin R
    Int J Clin Pharmacol Res; 1988; 8(2):123-6. PubMed ID: 3378854
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Pharmacokinetics of josamycin in liver cirrhosis].
    Okolicsanyi L; Miglioli PA; Venuti M; Orlando R; Iemmolo RM; Festa A; Grollo A; Berti T
    G Ital Chemioter; 1982; 29 Suppl 1():171-4. PubMed ID: 6927114
    [No Abstract]   [Full Text] [Related]  

  • 9. Pharmacokinetic study on the hepatic uptake of indocyanine green in cirrhotic patients.
    Kawasaki S; Sugiyama Y; Iga T; Hanano M; Sanjo K; Beppu T; Idezuki Y
    Am J Gastroenterol; 1985 Oct; 80(10):801-6. PubMed ID: 4036939
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glucuronidation of fenamates: kinetic studies using human kidney cortical microsomes and recombinant UDP-glucuronosyltransferase (UGT) 1A9 and 2B7.
    Gaganis P; Miners JO; Knights KM
    Biochem Pharmacol; 2007 May; 73(10):1683-91. PubMed ID: 17343829
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bile acid metabolism in patients with cirrhosis. I. Kinetic aspects of cholic acid metabolism.
    Vlahcevic ZR; Buhac I; Farrar JT; Bell CC; Swell L
    Gastroenterology; 1971 Apr; 60(4):491-8. PubMed ID: 5554239
    [No Abstract]   [Full Text] [Related]  

  • 12. Bile acid metabolism in patients with cirrhosis. II. Cholic and chenodeoxycholic acid metabolism.
    Vlahcevic ZR; Juttijudata P; Bell CC; Swell L
    Gastroenterology; 1972 Jun; 62(6):1174-81. PubMed ID: 5050315
    [No Abstract]   [Full Text] [Related]  

  • 13. Evidence for impairment of transsulfuration pathway in cirrhosis.
    Horowitz JH; Rypins EB; Henderson JM; Heymsfield SB; Moffitt SD; Bain RP; Chawla RK; Bleier JC; Rudman D
    Gastroenterology; 1981 Oct; 81(4):668-75. PubMed ID: 7262512
    [No Abstract]   [Full Text] [Related]  

  • 14. The formation of bile acids in patients with portal liver cirrhosis.
    Einarsson K; HEllström K; Schersten T
    Scand J Gastroenterol; 1975; 10(3):299-304. PubMed ID: 1138333
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oral and intravenous pharmacokinetics of cimetidine in liver cirrhosis.
    Okolicsanyi L; Venuti M; Orlando R; Lirussi F; Nassuato G; Benvenuti C
    Int J Clin Pharmacol Ther Toxicol; 1982 Oct; 20(10):482-7. PubMed ID: 7141756
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhanced renal clearance of uric acid in hepatic cirrhosis.
    Higuchi T; Nakamura T; Uchino H
    Isr J Med Sci; 1981 Nov; 17(11):1015-8. PubMed ID: 7319788
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Biopharmaceutical evaluation of the intrarectal use of mefenamic acid. III. Effect of solubilizers on the biological availability of mefenamic acid from witepsol H15].
    Kosior A
    Acta Pol Pharm; 1986; 43(2):156-60. PubMed ID: 3776655
    [No Abstract]   [Full Text] [Related]  

  • 18. Pharmacokinetics of ciprofloxacin in impaired liver function.
    Esposito S; Miniero M; Barba D; Sagnelli E
    Int J Clin Pharmacol Res; 1989; 9(1):37-41. PubMed ID: 2707924
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Abnormal methylation capacity in human liver cirrhosis.
    Geubel AP; Mairlot MC; Buchet JP; Dive C; Lauwerys R
    Int J Clin Pharmacol Res; 1988; 8(2):117-22. PubMed ID: 3378853
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cefoperazone pharmacokinetics in patients with liver cirrhosis: a predictive value of the ujoviridin test.
    Saudek F; Morávek J; Modr Z
    Int J Clin Pharmacol Ther Toxicol; 1989 Feb; 27(2):82-7. PubMed ID: 2921099
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.